OBSOLETE: Apodia, unilateral

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:295105
Who is this for?
Show terms as
8Treatment centers1Financial resources

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Unilateral apodia is an extremely rare congenital limb deficiency in which a person is born missing one foot. The term 'apodia' comes from Greek and literally means 'without a foot.' In this condition, one leg ends above where the foot would normally develop, while the other foot is present and normal. This happens during early pregnancy when the limbs are forming. The condition is present at birth and is usually noticed immediately. The Orphanet code 295105 for this condition is marked as obsolete, meaning it may now be classified under a broader category of limb reduction defects or terminal transverse limb deficiencies. The exact cause of unilateral apodia is not always known. It may occur as an isolated birth defect or as part of a broader syndrome. Possible causes include disruptions in blood flow to the developing limb, amniotic band syndrome (where strands of tissue wrap around the limb in the womb), or genetic factors. In many cases, no clear cause is found. Treatment focuses on helping the child achieve the best possible mobility and function. This typically involves fitting a prosthetic foot or lower limb device, physical therapy, and occupational therapy. Surgery may sometimes be needed to shape the limb for better prosthetic fitting. With modern prosthetics and supportive care, many individuals with unilateral apodia lead active and fulfilling lives.

Also known as:

Key symptoms:

Absence of one foot at birthShortened leg on the affected sideLeg length differenceDifficulty with balance and walkingPossible differences in muscle development of the affected leg

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

FDA & Trial Timeline

1 event
Jan 2026TEPADINA: New indication approved
FDAcompleted

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for OBSOLETE: Apodia, unilateral.

View clinical trials →

No actively recruiting trials found for OBSOLETE: Apodia, unilateral at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the OBSOLETE: Apodia, unilateral community →

No specialists are currently listed for OBSOLETE: Apodia, unilateral.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Financial Resources

1 resources

TEPADINA

Amneal Pharmaceuticals LLC

TEPADINA — Contact Amneal Pharmaceuticals LLC

Unverified — confirm before calling
Patient Assistance
Manufacturer Program
Accepting applications

Travel Grants

No travel grants are currently matched to OBSOLETE: Apodia, unilateral.

Search all travel grants →NORD Financial Assistance ↗

Community

Open OBSOLETE: Apodia, unilateralForum →

No community posts yet. Be the first to share your experience with OBSOLETE: Apodia, unilateral.

Start the conversation →

Latest news about OBSOLETE: Apodia, unilateral

No recent news articles for OBSOLETE: Apodia, unilateral.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What caused my child's limb difference, and should we pursue genetic testing?,At what age should we start prosthetic fitting?,How often will the prosthetic need to be replaced as my child grows?,What physical therapy program do you recommend?,Are there any associated conditions we should screen for?,Can you refer us to a family support group or peer network?,What adaptive sports or activities are available for children with limb differences?

Common questions about OBSOLETE: Apodia, unilateral

What is OBSOLETE: Apodia, unilateral?

Unilateral apodia is an extremely rare congenital limb deficiency in which a person is born missing one foot. The term 'apodia' comes from Greek and literally means 'without a foot.' In this condition, one leg ends above where the foot would normally develop, while the other foot is present and normal. This happens during early pregnancy when the limbs are forming. The condition is present at birth and is usually noticed immediately. The Orphanet code 295105 for this condition is marked as obsolete, meaning it may now be classified under a broader category of limb reduction defects or terminal

At what age does OBSOLETE: Apodia, unilateral typically begin?

Typical onset of OBSOLETE: Apodia, unilateral is neonatal. Age of onset can vary across affected individuals.

What treatment and support options exist for OBSOLETE: Apodia, unilateral?

1 patient support program are currently tracked on UniteRare for OBSOLETE: Apodia, unilateral. See the treatments and support programs sections for copay assistance, eligibility, and contact details.